May 13, 2016 / 11:12 AM / 2 years ago

BRIEF-Cardiome Q1 loss per share $0.06

May 13 (Reuters) - Cardiome Pharma Corp :

* Anticipate our first commercial sales of XYDALBA this year and a larger commercial roll-out during 2017

* Cardiome reports first quarter 2016 financial results

* Q1 loss per share $0.06

* Q1 revenue $7.1 million versus I/B/E/S view $6.3 million

* Q1 earnings per share view $-0.21 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below